LITMOTEF Trademark

Trademark Overview


On Thursday, May 15, 2014, a trademark application was filed for LITMOTEF with the United States Patent and Trademark Office. The USPTO has given the LITMOTEF trademark a serial number of 86282469. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 21, 2022. This trademark is owned by Glaxo Group Limited. The LITMOTEF trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
litmotef

General Information


Serial Number86282469
Word MarkLITMOTEF
Filing DateThursday, May 15, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 21, 2022
Registration Number4771479
Registration DateTuesday, July 14, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2015

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Friday, January 21, 2022CANCELLED SEC. 8 (6-YR)
Tuesday, July 14, 2020COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 14, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 28, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 28, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 24, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 16, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 11, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 11, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 10, 2015ASSIGNED TO LIE
Monday, March 2, 2015TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 4, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, September 4, 2014LETTER OF SUSPENSION E-MAILED
Thursday, September 4, 2014SUSPENSION LETTER WRITTEN
Friday, August 29, 2014ASSIGNED TO EXAMINER
Thursday, May 29, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, May 19, 2014NEW APPLICATION ENTERED IN TRAM